Cas:7473-93-0 2-Propen-1-one, 3- (2-nitrophenyl)-1-phenyl- manufacturer & supplier

Chemical Name:2-Propen-1-one, 3- (2-nitrophenyl)-1-phenyl-

CAS.NO:7473-93-0

Synonyms:(E)-3-(2-nitrophenyl)-1-phenyl-2-propen-1-one;Phenyl(2-nitrostyryl) ketone;3-(2-Nitrophenyl)-1-phenyl-2-propen-1-one;2-Propen-1-one, 3-(2-nitrophenyl)-1-phenyl-, (2E)-;1-phenyl-3-(2-nitrophenyl)-2-propen-1-one;(E)-1-phenyl-3-(2-nitrophenyl)prop-2-en-1-one;2-NITROCHALCONE;2-Nitro-trans-chalkon;MFCD00031069;2-Propen-1-one, 3-(2-nitrophenyl)-1-phenyl-, (E)-;(2E)-3-(2-Nitrophenyl)-1-phenyl-2-propen-1-one;2-nitro-trans-chalcone;trans-o-nitrochalcone;(2E)-3-(2-nitrophenyl)-1-phenylprop-2-en-1-one;2-Propen-1-one, 3- (2-nitrophenyl)-1-phenyl-;1-Phenyl-3-(2-nitrophenyl)-2-propene-1-one

Molecular Formula:C₁₅H₁₁NO₃

Molecular Weight:253.253

HS Code:

Physical and Chemical Properties:

Melting point:124-128°C

Boiling point:427.0±45.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.651

PSA:62.89000

Exact Mass:253.073898

LogP:3.56

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (E)-3-(2-nitrophenyl)-1-phenyl-2-propen-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Phenyl-3-(2-nitrophenyl)-2-propene-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Phenyl-3-(2-nitrophenyl)-2-propene-1-one Use and application,3-(2-Nitrophenyl)-1-phenyl-2-propen-1-one technical grade,usp/ep/jp grade.

Related News: Cholesterol drug Crestor, blood thinner Brilinta and acid reflux med Nexium have all suffered as a result. Brilinta, for example, saw emerging markets sales drop 40% at constant currencies to $180 million in the first six months of 2021. 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(1-pyrrolidinylthioxomethyl)thio]-, (4R,5S,6S)- manufacturers In addition, the government has made a series of new commitments, including: N-Cyclohexylmethyl-4-(2-oxo-1,2-dihydro-quinolin-5-yloxy)-butyramide suppliers After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million. 4-(4-Nitro-phenylazo)-benzoic acid (10Z,12E)-hexadeca-10,12-dienyl ester vendor & factory.